News Clips for Nov. 30, 2018

Utah Utes look to make more history against Washington Huskies in Pac-12 title game

History has been made for the Utah Utes. Now comes an opportunity to write it in an even more positive manner. After winning the Pac-12 South and reaching the championship game for the first time, the Utes find themselves just one victory away from an inaugural appearance in the “Granddaddy of Them All.” They would earn a berth in the Rose Bowl with a win over Washington on Friday (6 p.m., FOX) at Levi’s Stadium.

Genetically Modified Humans: Local scientist reacts

A Chinese researcher has claimed that he genetically modified human beings for the first time. He says that twin girls born earlier this month have been genetically modified to be resistant to HIV infection. Scientists internationally are incensed, saying that this researcher's actions are unethical.

6 hospitals planning upgrades, expansions

University of Utah's Huntsman Cancer Institute in Salt Lake City broke ground on the state's first proton therapy center Nov. 20.

LMWH Prevails for VTE Prevention in Guideline

Low-molecular-weight heparin (LMWH) retained a prominent role in the prevention of venous thromboembolism (VTE) in a comprehensive new clinical guideline from the American Society of Hematology (ASH). For inpatients who require VTE prophylaxis and do not have an increased bleeding risk, blood thinners are preferred over mechanical intervention, and LMWH is the preferred medication. LMWH received the nod over unfractionated heparin because of simpler administration and fewer complications. Mechanical prophylaxis is the preferred approach for patients with an increased bleeding risk.